Sponsor Pipeline

Beijing Biotech Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-06-12
31
Active Trials
31
Recruiting
10
Disease Areas
What Changed in the Last 30 Days
First PostedNew Trial FilingPhaseStatus
2026-06-11 NCT07641023 Dual-Target CAR-NK Cells Targeting MSLN, EGFR, or HER2 in Advanced NSCLC Phase 1/2 Recruiting
2026-06-11 NCT07641036 Dual-Target HER2/CEA CAR-NK Cells in Advanced Biliary Tract Cancer Phase 1/2 Recruiting
2026-06-11 NCT07641049 Dual-target PSMA/PSCA CAR-NK Cells in Advanced Prostate Cancer Phase 1 Recruiting
2026-06-04 NCT07627698 Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma Phase 1/2 Recruiting
2026-06-04 NCT07627711 Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic… Phase 1/2 Recruiting
2026-06-03 NCT07622940 Dual-Target CLDN18.2/HER2 CAR-NK Cells for Advanced Esophageal Adenocarcinoma Phase 1/2 Recruiting
2026-06-01 NCT07617753 Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2 Phase 1/2 Recruiting
2026-06-01 NCT07617805 EGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCC Phase 1/2 Recruiting
2026-05-20 NCT07598955 Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2… Phase 1/2 Recruiting
2026-05-15 NCT07589517 Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer Phase 1/2 Recruiting
Active Trials by Phase
Phase 1/2
27
Phase 1
4
Active Trials — top 25 of 31
NCT IDTitleConditionStatus
Phase 1/2
NCT07462650 Dual-Target CAR-NK Cells for Biomarker-Selected Advanced Colorectal Cancer Colorectal Cancer Metastatic Recruiting
NCT07467863 Dual-Target CAR-NK Cells Directed Against MSLN, EGFR, or HER2 in Advanced NSCLC Non-Small Cell Lung Cancer Recruiting
NCT07480213 Adaptive Phase 1/2 Study of Dual-Target CAR-NK Cells in Relapsed/Refractory Small Cell… Small Cell Lung Cancer (SCLC) Recruiting
NCT07480928 Dual-Targeting CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic… Pancreatic Ductal Adenocarcinoma (PDAC) Recruiting
NCT07480954 Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) Epithelial Ovarian Cancer Recruiting
NCT07486089 Dual-Target CAR-NK Cells for Advanced Breast Cancer (HER2+ and TNBC) Breast Cancer (Locally Advanced or Metastatic) Recruiting
NCT07500220 Dual-Target GPC3/B7-H3 CAR-NK Cells for Advanced HCC Advanced Hepatocellular Carcinoma (HCC) Recruiting
NCT07502287 Dual-Target GD2/B7-H3 CAR-NK Cells for Pediatric Relapsed or Refractory Neuroblastoma Relapsed Neuroblastoma Recruiting
NCT07510802 Dual-Target CAR-NK Cells for Advanced Breast Cancer HER2+ TNBC Breast Cancer (Advanced/Metastatic) Recruiting
NCT07510815 Dual-Target MSLN/FAP CAR-NK Cells for Pleural and Peritoneal Mesothelioma Malignant Pleural Mesotheliomas Recruiting
NCT07510828 PRISM-NK: Precision-Matched Allogeneic Single- or Dual-Target CAR-NK Cells for Advanced… Advanced or Metastatic Solid Tumors Recruiting
NCT07523529 Biomarker-Guided Dual-Target CAR-T Cells for Advanced Solid Tumors Advanced Unresectable Recruiting
NCT07523542 SELECT-SLE: Biomarker-Guided CAR-T Target Selection for Refractory Lupus REFRACTORY SYSTEMIC LUPUS ERYTHEMATOSUS Recruiting
NCT07523555 Adaptive Dual-Target CAR-T Cells for Relapsed or Refractory Hematologic Malignancies Relapsed/Refractory B-cell Acute Lymphoblastic Leukemia Recruiting
NCT07551349 Dual-target CD70/CAIX CAR-NK Cells for Advanced Clear Cell Renal Cell Carcinoma Advanced or Metastatic Clear Cell Renal Cell Carcinoma Recruiting
NCT07551362 Dual-target CLDN18.2/HER2 CAR-NK Cells for Advanced Gastric/GEJ Cancer Advanced Gastric Adenocarcinoma Recruiting
NCT07589517 Dual-Targeting CAR-NK Cells in Biomarker-Selected Advanced Colorectal Cancer Colorectal Cancer Recruiting
NCT07589530 Phase 1/2 Study of EB-NK-301 (Allogeneic TROP2-CAR NK Cells) in Advanced TROP2-Expressing… Advanced Solid Tumors Recruiting
NCT07589543 Dual-Target CAR-NK Cells in Recurrent or Refractory Epithelial Ovarian Cancer Epithelial Ovarian Cancer Recruiting
NCT07598955 Target-Selected CAR-NK Cells (CD30, CD5, or Mesothelin) for Relapsed/Refractory B2… B2 Thymoma Recruiting
NCT07617753 Dual-Targeting CAR-NK Cells for Recurrent Ovarian Cancer (MSLN, FRα, MUC16) pt2 Epithelial Ovarian Cancer Recruiting
NCT07617805 EGFR/HER2 Dual-Target CAR-NK Cells for Recurrent or Metastatic HNSCC Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Recruiting
NCT07622940 Dual-Target CLDN18.2/HER2 CAR-NK Cells for Advanced Esophageal Adenocarcinoma Recurrent or Metastatic Esophageal Adenocarcinoma Recruiting
NCT07627698 Dual-Target CSPG4/GD2 CAR-NK Cells for Advanced Melanoma Unresectable Melanoma Recruiting
NCT07627711 Dual-Target CAR-NK Cells Targeting Mesothelin (MSLN) and MUC1 in Advanced Pancreatic… Pancreatic Ductal Adenocarcinoma (PDAC) Recruiting
View all 31 active Beijing Biotech trials with filters →
Disease Areas
Get alerts when Beijing Biotech's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free